CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Fine particulate air pollution and hospital admissions and readmissions for acute myocardial infarction in 26 Chinese cities Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study

Review Article2020 Jun 5;S0033-0620(20)30123-7.

JOURNAL:Prog Cardiovasc Dis. Article Link

Acute Myocardial Injury in Patients Hospitalized With COVID-19 Infection: A Review

C Bavishia, RO Bonow, DL Bhatt et al. Keywords: biomarkers; COVID-19; management; myocardial injury; prognosis

ABSTRACT